JP2023536068A5 - - Google Patents

Info

Publication number
JP2023536068A5
JP2023536068A5 JP2023503219A JP2023503219A JP2023536068A5 JP 2023536068 A5 JP2023536068 A5 JP 2023536068A5 JP 2023503219 A JP2023503219 A JP 2023503219A JP 2023503219 A JP2023503219 A JP 2023503219A JP 2023536068 A5 JP2023536068 A5 JP 2023536068A5
Authority
JP
Japan
Prior art keywords
crystal
crystal according
peaks
cancer
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023503219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023536068A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033618 external-priority patent/WO2022019998A1/en
Publication of JP2023536068A publication Critical patent/JP2023536068A/ja
Publication of JP2023536068A5 publication Critical patent/JP2023536068A5/ja
Pending legal-status Critical Current

Links

JP2023503219A 2020-07-20 2021-05-21 クレノラニブの結晶形態およびそれを用いる方法 Pending JP2023536068A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063053921P 2020-07-20 2020-07-20
US63/053,921 2020-07-20
PCT/US2021/033618 WO2022019998A1 (en) 2020-07-20 2021-05-21 Crystal forms of crenolanib and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023536068A JP2023536068A (ja) 2023-08-23
JP2023536068A5 true JP2023536068A5 (cg-RX-API-DMAC7.html) 2024-01-24

Family

ID=79460325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023503219A Pending JP2023536068A (ja) 2020-07-20 2021-05-21 クレノラニブの結晶形態およびそれを用いる方法

Country Status (4)

Country Link
EP (1) EP4181923A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023536068A (cg-RX-API-DMAC7.html)
CN (1) CN113956245A (cg-RX-API-DMAC7.html)
CA (1) CA3186319A1 (cg-RX-API-DMAC7.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8580301A1 (es) * 2002-08-28 2005-05-24 Pfizer Prod Inc Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos
EP1641780B1 (en) * 2003-06-24 2008-11-12 Pfizer Products Incorporated Processes for the preparation of 1- [(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives
KR101738063B1 (ko) * 2012-09-21 2017-05-19 아로그 파마슈티칼스, 인코퍼레이티드 구조적으로 활성인 인산화된 ｆｌｔ３ 키나제의 억제 방법
TWI599356B (zh) * 2012-09-26 2017-09-21 安羅格製藥有限責任公司 抑制突變型ｃ－ｋｉｔ的方法
BR112015016282A2 (en) * 2013-01-07 2017-07-11 Arog Pharmaceuticals, Inc. crenolanib for treatment of mutated flt3 proliferative disorders
CN105294719B (zh) * 2015-11-18 2017-12-22 乳源瑶族自治县大众药品贸易有限公司 一种氨基喹唑啉类衍生物的二对甲苯磺酸盐及其晶型
EA201991078A1 (ru) * 2016-11-02 2019-11-29 Креноланиб для лечения пролиферативных расстройств, связанных с мутацией flt3
CN110840893A (zh) * 2018-12-13 2020-02-28 安罗格制药有限责任公司 含克莱拉尼的药物组合物及其用途

Similar Documents

Publication Publication Date Title
JP2006528973A5 (cg-RX-API-DMAC7.html)
ES2670864T3 (es) Inhibidores de histonas desmetilasas
CN104981458B (zh) 组蛋白去甲基化酶抑制剂
JP2022186995A5 (cg-RX-API-DMAC7.html)
CA3019450A1 (en) Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application
JP2020517616A5 (cg-RX-API-DMAC7.html)
JP2020528907A5 (cg-RX-API-DMAC7.html)
CN108606979A (zh) 包含六氧化四砷的多晶型物的用于预防或治疗癌的药物组合物
JP2010501572A5 (cg-RX-API-DMAC7.html)
JP2011126896A5 (cg-RX-API-DMAC7.html)
JP2016528179A5 (cg-RX-API-DMAC7.html)
JP2006519862A5 (cg-RX-API-DMAC7.html)
JP2024099797A (ja) ７－シクロペンチル－２－（５－ピペラジン－１－イル－ピリジン－２－イルアミノ）－７Ｈ－ピロロ［２，３－ｄ］ピリミジン－６－カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態
JP2021519262A5 (cg-RX-API-DMAC7.html)
CN108366979B (zh) 与泛素化－蛋白酶体系统有关的化合物及医药组合物
JP2017526662A5 (cg-RX-API-DMAC7.html)
JP2022534788A5 (cg-RX-API-DMAC7.html)
CN117062819A (zh) 多环化合物及其用途
KR20120015363A (ko) Ｎ-［6-(시스-2,6-디메틸모르폴린-4-일)피리딘-3-일］-2-메틸-4'-(트리플루오로메톡시)［1,1'-비페닐］-3-카르복스아미드의 염
JP2023536068A5 (cg-RX-API-DMAC7.html)
JP2023515687A5 (cg-RX-API-DMAC7.html)
JP2024509276A5 (cg-RX-API-DMAC7.html)
IL233988A (en) Aurora kinase and flt3 kinase modulators
JP2010500971A5 (cg-RX-API-DMAC7.html)
RU2023104666A (ru) Твердая форма соединения